Rapid measurement of formed blood component sedimentation rate from small sample volumes

Patent metadata

Field	Value
Publication number	US-10788409-B2
Application number	US-201816001760-A
Country	US
Kind code	B2
Filing date	Jun 6, 2018
Priority date	Jul 18, 2012
Publication date	Sep 29, 2020
Grant date	Sep 29, 2020

Abstract

Devices and methods are described for measuring formed blood component sedimentation rate. Some of the methods may use (1) centrifugal techniques for separating red blood cells from plasma and (2) video and/or still imaging capability. Both may be used alone or in combination to accelerate formed blood component sedimentation and to measure its rate. In one example, the method may advantageously enable rapid measurement of sedimentation rate using small blood sample volumes. Automated image analysis can be used to determine both sedimentation rate and hematocrit. Automated techniques may be used to compensate for effects of hematocrit on uncorrected sedimentation rate data.

First claim

What is claimed is:

1. A method comprising:
using an accelerated blood component separation technique using a first compaction force on a blood sample for a first period of time, wherein the accelerated blood component separation technique occurs at a first module of a benchtop, point-of-service system and wherein the blood sample is contained in a non-capillary vessel;
imaging the vessel to determine a first position of formed component and plasma boundary in the vessel;
using the accelerated blood component separation technique on the blood sample for a second period of time at a second compaction force greater than the first compaction force associated with the first period of time;
imaging the vessel to determine a second position of formed component and plasma boundary in the vessel after the second time period;
determining a time-related compaction curve for at least one formed blood component in said blood sample after accelerated blood component separation based on the first position and the second position, said compaction curve having an initial approximately linear portion; and
determining sedimentation rate of the formed blood component in said accelerated blood component separation technique, based on at least the linear portion of the compaction curve and a hematocrit correction factor based on a hematocrit of the sample.

2. The method of claim 1 wherein the accelerated blood component separation technique comprises centrifuging the blood sample.

3. The method of claim 2 , wherein formed component and plasma boundary comprise an erythrocyte/plasma interface boundary.

4. The method of claim 2 , further comprising image transformation for conversion of a curved liquid interface to a flat interface.

5. The method of claim 2 , further comprising using a processor programmed to record interface position during a least a portion of centrifugation.

6. The method of claim 2 wherein the non-capillary vessel comprises a centrifuge vessel.

7. The method of claim 1 comprises correcting for hematocrit effect on sedimentation rate by using the hematocrit correction factor based on the formula:

U
corr

=

U
uncorr

(

1
-

φ

φ
max

)

γ

,

where U uncorr and U corr are the uncorrected (raw) and corrected sedimentation rates, φ is the volume fraction of cells (hematocrit), and φ max and γ are empirical parameters obtained by curve fitting.

8. The method of claim 7 wherein curve fitting for the hematocrit correction factor comprises calibrating sedimentation rates from centrifuge based technique with sedimentation rates from a reference technique.

9. The method of claim 8 , wherein the reference technique is the Westergren technique.

10. The method of claim 1 , wherein correcting for hematocrit comprises calculating a mathematical function for a plurality of formed blood component interface positions occurring in said curve, said function being operative to correct for sedimentation rate variations due to hematocrit.

11. The method of claim 1 wherein the blood sample being processed has a volume in the vessel of about 20-25 μL.

12. A method comprising:
using an accelerated blood component separation technique using a first compaction force on a blood sample for a first period of time, wherein the accelerated blood component separation technique occurs at a first module of a benchtop, point-of-service system and wherein the blood sample is contained in a non-capillary vessel;
imaging the vessel to determine a first position of formed component and plasma boundary in the vessel;
using the accelerated blood component separation technique on the blood sample for a second period of time at a second compaction force greater than the first compaction force associated with the first period of time;
imaging the vessel to determine a second position of formed component and plasma boundary in the vessel after the second time period;
determining a time-related compaction curve for at least one formed blood component in said blood sample after accelerated blood component separation based on the first position and the second position, said compaction curve having an initial approximately linear portion; and
determining sedimentation rate of the formed blood component in said accelerated blood component separation technique, based on at least the linear portion of the compaction curve and a hematocrit correction factor based on a hematocrit of the sample;
wherein the blood sample is an anti-coagulated sample.

13. A method comprising:
using an accelerated blood component separation technique using a first compaction force on a blood sample for a first period of time, wherein the accelerated blood component separation technique occurs at a first module of a benchtop, point-of-service system and wherein the blood sample is contained in a non-capillary vessel;
imaging the vessel to determine a first position of formed component and plasma boundary in the vessel;
using the accelerated blood component separation technique on the blood sample for a second period of time at a second compaction force greater than the first compaction force associated with the first period of time;
imaging the vessel to determine a second position of formed component and plasma boundary in the vessel after the second time period;
determining a time-related compaction curve for at least one formed blood component in said blood sample after accelerated blood component separation based on the first position and the second position, said compaction curve having an initial approximately linear portion; and
determining sedimentation rate of the formed blood component in said accelerated blood component separation technique, based on at least the linear portion of the compaction curve and a hematocrit correction factor based on a hematocrit of the sample;
wherein said blood sample is about 100 μL or less.

14. The method of claim 13 wherein said blood sample is about 50 μL or less.

Assignees

• Theranos Ip Co Llc
• Labrador Diagnostics Llc

Inventors

• Dayel Mark
• Anekal Samartha
• Holmes Elizabeth A

Classifications

• G01N2015/055

  for hematocrite determination · CPC title

• G01N2015/045

  by optical analysis · CPC title

• G01N15/05 Primary

  in blood · CPC title

• G01N15/042 Primary

  by centrifuging and investigating centrifugates (centrifuges per se B04B) · CPC title

• B01D21/32

  Density control of clear liquid or sediment, e.g. optical control {; Control of physical properties} · CPC title